Kiromic BioPharma Inc.

1.50
0.00 (0.00%)
At close: Feb 28, 2025, 3:17 PM
0.00
-100.00%
After-hours: Dec 31, 1969, 07:00 PM EST

Kiromic BioPharma Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.87 -1.35 -2.32 -20.43 -96.39 -356.89 -319.43
PEG Ratio 0.01 0.02 -0.57 1.38 -0.56 34.01 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio -1.86 -3.14 -15.34 19.18 162.92 676.35 4.59K
P/FCF Ratio -1.18 -1.34 -3.09 -23.59 -244.07 -416.12 -532.2
P/OCF Ratio -1.21 -1.35 -3.73 -25.79 -302.14 -459.35 -566.14
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -1.16 -1.7 -1.63 0.02 0.04 n/a n/a
Quick Ratio 0.16 0.22 0.13 7.94 7.32 3.00 0.89
Current Ratio 0.16 0.22 0.13 7.94 7.32 3.03 0.92
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage 6.39 10.77 -186.87 -2.11K -5.82K -164.68 -5.03
Return on Equity (ROE) 2.14 2.33 6.61 -0.94 -1.69 -1.9 -14.38
Return on Assets (ROA) -3.15 -1.75 -3.19 -0.83 -1.5 -1.41 -4.36
Return on Capital (ROIC) 1.92 2.43 23.65 -0.94 -1.69 -1.87 -12
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a